Schonfeld Strategic Advisors’s Transmedics TMDX Stock Holding History

Schonfeld Strategic Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-91,065	Closed	-$11.1M	–	2671
2025 Q4	$11.1M	Buy	91,065 +64,730	+246%	+$8.12M	0.05%	324
2025 Q3	$2.95M	Buy	+26,335	New	+$3.08M	0.02%	842
2024 Q4	–	Sell	-5,155	Closed	-$809K	–	2383
2024 Q3	$809K	Buy	+5,155	New	+$794K	0.01%	1231
2023 Q4	–	Sell	-4,500	Closed	-$246K	–	2214
2023 Q3	$246K	Buy	4,500 +526	+13%	+$37.9K	﹤0.01%	1363
2023 Q2	$334K	Sell	3,974 -18,764	-83%	-$1.44M	﹤0.01%	1363
2023 Q1	$1.72M	Sell	22,738 -26,503	-54%	-$1.83M	0.02%	736
2022 Q4	$3.04M	Buy	49,241 +20,541	+72%	+$1.09M	0.03%	663
2022 Q3	$1.2M	Buy	+28,700	New	+$1.25M	0.01%	1158
2021 Q3	–	Sell	-6,700	Closed	-$222K	–	2463
2021 Q2	$222K	Buy	+6,700	New	+$186K	﹤0.01%	1619

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Schonfeld Strategic Advisors's TMDX Position: Q1 2026 in Review

Schonfeld Strategic Advisors sold out of Transmedics (TMDX) in Q1 2026, closing a stake of 91,065 shares — an estimated $11.1M sold.

Schonfeld Strategic Advisors first reported a position in TMDX in Q2 2021 and held it in 9 quarters. The position peaked at $11.1M in Q4 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

Schonfeld Strategic Advisors reported no remaining Transmedics position as of Q1 2026 after selling out during the quarter.
Schonfeld Strategic Advisors sold 91,065 Transmedics shares in Q1 2026, an estimated $11.1M.
Schonfeld Strategic Advisors first reported a position in Transmedics in Q2 2021 and held it in 9 quarters.
Schonfeld Strategic Advisors's Transmedics position peaked at $11.1M in Q4 2025.
414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.